Abstract
Many surgical advancement paved to surgical success in endonasal endoscopic dacryocystorhinostomy. Mitomycin C is a systemic chemotherapeutic agent derived from Streptomyces caespitosus that inhibits the synthesis of DNA, cellular RNA, and protein by inhibiting the synthesis of collagen by fibroblasts. The objective of the study was to evaluate the advantage of mitomycin C in primary endoscopic endonasal dacryocystorhinostomy without stenting. Randomised case control design. Tertiary academic centre in central India. 112 patients who presented with epiphora and diagnosed as chronic dacryocystitis after syringing by ophthalmologist, were selected and randomised into two groups with or without mitomycin C intraoperative application. 112 eyes underwent endoscopic-dacryocystorhinostomy. Additional surgeries were done according to necessity. Mitomycin C was applied in concentration of 0.4 mg/dl for 5 min. Patients were followed up on OPD-basis at the end of 1st week, 1st month, 3rd month and over phone call at end of 1 year. Symptomatic improvement assessed by verbal enquiry and clinically by syringing by ophthalmologist. 8 patients underwent septal surgery in case group and 4 in control group along with 1 concha bullosa correction in the case group (p < 0.05). Nil intraoperative complications (p < 0.05) and nil postoperative complication noted (p < 0.05). Functional and anatomical patency found to be 100% at the end of 1st week in both groups, 96.5% at 3rd month in case group and 96.4% and 92.9% at 1 month and 3 month respectively in control group. Nasal endoscopy of all surgical failures showed restenosis in both case group and control group except 1 patient with granulation in control group. Eventhough intraoperative mitomycin C application is effective in increasing the success rate of endonasal DCR surgery in standard nasolacrimal duct obstruction, and with no significant complications from its use, the study did not show added benefit in the primary endoscopic endoscopic dacryocystorhinostomy without stenting.
Similar content being viewed by others
References
Caldwell GW (1893) Two new operations for obstruction of the nasal duct with preservation of the canaliculi. Am J Ophthalmol 10:189–191
McDonogh M, Meiring JH (1989) Endoscopic transnasal dacryocystorhinostomy. J Laryngol Otol 103:585–587
Kennedy DW (1985) Functional endoscopic sinus surgery technique. Arch Otolaryngol Head Neck Surg 111(10):643–649
Korkut AY, Teker AM, Yazici MZ, Kahya V, Gedikli O et al (2010) Surgical outcomes of primary and revision endoscopic dacryocystorhinostomy. J Craniofac Surg 21:1706–1708
Leong SC, MacEwen CJ, White PS (2010) A systematic review of outcomes after dacryocystorhinostomy in adults. Am J Rhinol Allergy 24:81–90
Cheng S, Feng Y, Xu L, Li Y, Huang J (2013) Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis. PLoS One 8(5):e62737
Apuhan T, Yıldırım YS, Eroglu F, Sipahier A (2011) Effect of mitomycin C on endoscopic dacryocystorhinostomy. J Craniofac Surg 22:2057–2059
Zílelíoğlu G, Tekeli O, Uğurba SH, Akiner M, Aktürk T et al (2002) Results of endoscopic endonasal non-laser dacryocystorhinostomy. Doc Ophthalmol 105:57–62
Yildirim C, Yaylali V, Esme A, Ozden S (2007) Long-term results of adjunctive use of mitomycin C in external dacryocystorhinostomy. Int Ophthalmol 27:31–35
Prasannaraj T, Kumar BY, Narasimhan I, Shivaprakash KV (2012) Significance of adjunctive mitomycin C in endoscopic dacryocystorhinostomy. Am J Otolaryngol 33(47–50):18
Cokkeser Y, Evereklioglu C, Er H (2000) Comparative external versus endoscopic dacryocystorhinostomy: results in 115 patients (130 eyes). Otolaryngol Head Neck Surg 123:488–491
McMasters M, Messerli J, Wolfensberger M (2000) Endonasal dacryocystorhinostomy: technique and results. Schweiz Med Wochenschr Suppl 116:74S–76S
Pittore B, Tan N et al (2010) Endoscopic transnasal dacryocystorhinostomy without stenting: results in 64 consecutive procedures. Acta Otorhinolaryngol Ital 30:294–298
Mudhol RR, Zingade ND, Mudhol RS, Das A (2012) Endoscopic ostium assessment following endonasal dacryocystorhinostomy with mitomycin C application. Al Ameen J Med Sci 5:320–324
Mann BS, Wormald PJ (2006) Endoscopic assessment of the dacryocystorhinostomy ostium after endoscopic surgery. Laryngoscope 116:1172–117440
Boush GA, Lemke BN, Dortzbach RK (1994) Results of endonasal laser-assisted dacryocystorhinostomy. Ophthalmology 101:955–959
Kong YT, Kim TI, Kong BW (1994) A report of 131 cases of endoscopic laser lacrimal surgery. Ophthalmology 101:1793–1800
Woog JJ, Metson R, Puliafito CA (1993) Holmium: YAG endonasal laser dacryocystorhinostomy. Am J Ophthalmol 116:1–10
Rubinfield RS, Pfister RR, Stein RM, Foster CS, Martin NF et al (1992) Serious complications of topical mitomycin C after pterygium surgery. Ophthalmology 99:1647–1654
Zacharria PT, Depperrman SR, Schuman JS (1993) Ocular hypotony after trabeculectomy with mitomycin C. Am J Ophthalmol 116:314–336
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Jayantha Kedilaya, Y., Chacko, A. & Poorey, V.K. Improving the Results of Endonasal Dacryocystorhinostomy with Mitomycin C Application: A Prospective Case–Control Study. Indian J Otolaryngol Head Neck Surg 70, 477–481 (2018). https://doi.org/10.1007/s12070-018-1498-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-018-1498-x